SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that PROMACTA® (eltrombopag), a drug discovered in collaboration with GlaxoSmithKline (NYSE:GSK), was recognized as “Best Biotechnology Product” by the Prix Galien USA committee on October 1, 2009. The 2009 Prix Galien USA is the pharmaceutical industry’s highest R&D accolade for treatments that could change the course of healthcare worldwide. The Prix Galien Award recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is considered the equivalent to the Nobel Prize.
